FFWD #253 with Heliad Co-CEO Falk Schäfers
Read more
.png)
Why we invested in Dynamic Creatures
Every wave of robotics has needed a proving ground before it got a market. Industrial robotics proved itself on the assembly line. Defence robotics is proving itself now, across Europe's rearmament programmes and around critical infrastructure. Both sit in our resilience portfolio. The third wave is consumer and experience robotics, and it will prove itself in queues, lobbies and check-in counters long before it reaches anyone's living room. That proof has to come from characters people actually want to meet.
Heliad Equity Partners participates in NewtonX’s $32m Series B funding round
Frankfurt am Main, 16th of December 2021 – Heliad Equity Partners GmbH & Co. KGaA (ISIN: DE000A0L1NN5) welcomes NewtonX to
.png)
Why we invested in Sci2sci
Pharma R&D is the industry that would benefit most from intelligence over its own data, yet it is the most underserved in getting it. sci2sci is building the layer that changes that. Biopharma first, high-reg industries beyond it next.